Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3457541 | 0.85 | ALDH1A1 (0.33) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL869827 | 0.84 | CES2 (0.40) | MEN1ALDH1A1KMT2A | |
| SCHEMBL546145 | 0.84 | CES2 (0.40) | MEN1ALDH1A1KMT2A | |
| SCHEMBL28892225 | 0.80 | MEN1 (0.32) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL28892224 | 0.80 | MEN1 (0.32) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL5176057 | 0.76 | CES2 (0.39) | MEN1ALDH1A1KMT2A | |
| SCHEMBL30105448 | 0.74 | DNM1 (0.36) | MEN1KMT2A | |
| SCHEMBL5480138 | 0.72 | — | — | |
| SCHEMBL9279731 | 0.70 | ALDH1A1 (0.33) | MEN1ALDH1A1CYP1A2THRBKMT2A | |
| SCHEMBL580695 | 0.70 | ALDH1A1 (0.38) | MEN1ALDH1A1CYP1A2THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7759285-B2 | Mixture of a salt of 3-(dimethylamino)-2-(hydroxyl)-butylate and an amine compound of 3,3'-diaminopropylamine, 4-aminomethylpiperidine, or 2-aminomethylpiperidine which promotes the reaction | KOREA ELECTRIC POWER CORPORATION (KR) | 2010-07-20 | — | — | US | claimed |
| CN-101190397-A | Absorbent for separation of carbon dioxide | KOREA ELECTRIC POWER CORP (KR) | 2008-06-04 | — | — | CN | claimed |
| US-20080125314-A1 | Mixture of a salt of 3-(dimethylamino)-2-(hydroxyl)-butylate and an amine compound of 3,3'-diaminopropylamine, 4-aminomethylpiperidine, or 2-aminomethylpiperidine which promotes the reaction | KOREA ELECTRIC POWER CORPORATION (KR) | 2008-05-29 | — | — | US | claimed |
| CN-101190397-B | Absorbent for separation of carbon dioxide | KOREA ELECTRIC POWER CORP | 2011-09-14 | — | — | CN | disclosed |
| US-7759285-B2 | Mixture of a salt of 3-(dimethylamino)-2-(hydroxyl)-butylate and an amine compound of 3,3'-diaminopropylamine, 4-aminomethylpiperidine, or 2-aminomethylpiperidine which promotes the reaction | KOREA ELECTRIC POWER CORPORATION (KR) | 2010-07-20 | — | — | US | disclosed |
| CN-101190397-A | Absorbent for separation of carbon dioxide | KOREA ELECTRIC POWER CORP (KR) | 2008-06-04 | — | — | CN | disclosed |
| US-20080125314-A1 | Mixture of a salt of 3-(dimethylamino)-2-(hydroxyl)-butylate and an amine compound of 3,3'-diaminopropylamine, 4-aminomethylpiperidine, or 2-aminomethylpiperidine which promotes the reaction | KOREA ELECTRIC POWER CORPORATION (KR) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125314-A1 | Mixture of a salt of 3-(dimethylamino)-2-(hydroxyl)-butylate and an amine compound of 3,3'-diaminopropylamine, 4-aminomethylpiperidine, or 2-aminomethylpiperidine which promotes the reaction | SLC7A1, ALDH7A1, DDC | MEN1 3795/4885ALDH1A1 106/4885CYP1A2 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.